PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.\', \'Beijing Kohnoor Science & Technology Co., Ltd, 102206, Beijing, China.\', \'Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.\', \'Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, 100050, Beijing, China.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.\', \'Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.\', \'Ludwig Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK. ericshuochen@gmail.com.\', \'Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China. xun.gui@mabwell.com.\', \'Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China. yzm@wh.iov.cn.\', \'Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China. datao.liu@mabwell.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-020-19568-1
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33188207
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all